-
LABORATORY
-
Genewel Research InstituteThrough continuous research and development in regenerative medicine, we are securing sustainable growth drivers. By expanding our product portfolio based on biomaterial technologies, we contribute to improving quality of life across diverse industries — including healthcare and aesthetics — with differentiated regenerative solutions.
-
R&D TECHNOLOGY
-
Platform TechnologyRegenerative
BiomaterialsSmart
Formulation-
01Regenerative Material Platform
- We possess an integrated platform technology centered on regenerative materials — covering the entire process from extraction and synthesis to analysis and selection of natural and synthetic polymers — to support tissue regeneration, functional recovery, and adjunct therapy.
-
02Smart Release System
- We possess technology that controls drug release in accordance with the tissue environment and recovery stage, enabling precise delivery of functional substances to target sites.
-
03Regenerative Engineering Platform
- We possess technology to design various regenerative medical materials in optimal formulations through natural and synthetic polymer processing techniques, including morphology-controlled freeze-drying and Smart Pore foaming technology.
-
-
FIELD
-
Research & Development AreasBasic Research of
Regenerative
BiomaterialsDesign and development of functional regenerative materials applicable across all areas of regenerative medicine- Biopolymer material technologies including hyaluronic acid, PN, collagen, ECM, and PLA
- Decellularization technology for Acellular Dermal Matrix (ADM)
- Tissue Regeneration
-
Based on our Regenerative Material Platform technology,
we develop next-generation tissue regeneration solutions
utilizing biopolymer materials.
- Wound Dressings
- Periodontal Tissue Regeneration
- Tissue Augmentation
- Post-Surgery Recovery Care
-
We provide high-performance recovery care solutions
that accelerate post-surgical recovery and tissue regeneration.
- Pain Management System
- Anti-adhesion Agent
- Hemostasis
-
We develop high-performance hemostatic agents that deliver
excellent hemostatic efficacy across a variety of bleeding environments.
- Flowable Surgical Hemostatic Agent
- Sealant Hemostatic Agent
- Endoscopic Hemostatic Agent
- Medical Aesthetics
-
We research aesthetic solutions that achieve skin regeneration
and slow aging through high-performance natural
and synthetic polymers.
- Derma Cosmetic
- Dermal Filler
- Bio Stimulator
-
INFRA
-
Patents & Awards
Domestic Patents: 34, International Patents: 23
Minister of Trade, Industry and Energy Award on Invention Day ('21)
Recognized for foam foaming, domestic localization of biomaterial technology, and differentiated DDS technology
KIPO — Certified as an Excellent Company in Employee Invention Compensation ('20)
Recognized for fostering outstanding patent creation through the employee invention compensation program
